Characterization and in vitro activities of cell-free antigens from Histoplasma capsulatum-loaded biodegradable microspheres

European Journal of Pharmaceutical Sciences

Volumn 38, Issue 5, 2009, Pages 548-555

  dos Santos, Daiane F ^a   Nicolete, Roberto ^a   de Souza, Patrícia R M ^a   Bitencourt, Cláudia da S ^a   dos Santos Junior, Rubens R ^a   Bonato, Vânia L D ^a   Silva, Célio L ^a   Faccioli, Lúcia H ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Biodegradable microspheres; Cell activation; Cell free antigens; Macrophages; Phagocytosis

Indexed keywords

FUNGUS VACCINE; HISTOPLASMA CAPSULATUM VACCINE; MICROSPHERE; NITRIC OXIDE; POLYGLACTIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BIODEGRADABILITY; CONTROLLED DRUG RELEASE; CONTROLLED STUDY; CYTOKINE PRODUCTION; HISTOPLASMA CAPSULATUM; IMMUNIZATION; IMMUNOSTIMULATION; IN VITRO STUDY; MACROPHAGE; MICROENCAPSULATION; MOUSE; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; SUSTAINED DRUG RELEASE;

ANIMALS; ANTIGENS, FUNGAL; BIOCOMPATIBLE MATERIALS; CELLS, CULTURED; HISTOPLASMA; MICE; MICROSPHERES; SUBCELLULAR FRACTIONS;

EID: 70449532022     PISSN: 09280987     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejps.2009.10.003     Document Type: Article

References (33)

1. Austyn J.M., and Gordon S. F4/80, a monoclonal antibody directed specifically against the mouse macrophage. Eur. J. Immunol. 11 10 (1981) 805-815
2. Bazile D.V., Ropert C., Huve P., Verrechia T., Marland M., Frydman A., Veillard M., and Spenlehauer G. Body distribution of fully biodegradable 14C-poly(lactic acid) nanoparticles coated with albumin after parenteral administration to rats. Biomaterials 13 (1992) 1093-1102
3. Cano M.V., and Hajjeh R.A. The epidemiology of histoplasmosis: a review. Semin. Respir. Infect. 16 (2001) 109-118
4. Champion J.A., Walker A., and Mitragotri S. Role of particle size in phagocytosis of polymeric microspheres. Pharm. Res. 25 8 (2008) 1815-1821
5. Deepe Jr. G.S., and Durose G.G. Immunobiological activity of recombinant H antigen from Histoplasma capsulatum. Infect. Immun. 63 (1995) 3151-3157
6. Deepe Jr. G.S., and Gibbons R. Protective efficacy of H antigen from Histoplasma capsulatum in a murine model of pulmonary histoplasmosis. Infect. Immun. 69 (2001) 3128-3134
7. Deepe Jr. G.S., and Gibbons R.S. T cells require tumor necrosis factor-α to provide protective immunity in mice infected with Histoplasma capsulatum. J. Infect. Dis. 193 2 (2006) 322-330
8. Eldridge J.H., Staas J.K., Meulbroek J.A., Tice T.R., and Gilley R.M. Biodegradable and biocompatible poly(dl-lactide-co-glycolide) microspheres as an adjuvant for staphylococcal enterotoxin B toxoid which enhances the level of toxin-neutralizing antibodies. Infect. Immun. 59 (1991) 2978-2986
9. Faisal S.M., Weiwei Y., McDonough S.P., and Chang Y. Leptospira immunoglobulin-like protein A variable region (LigAvar) incorporated in liposomes and PLGA microspheres produces a robust immune response correlating to protective immunity. Vaccine 27 (2009) 378-387
10. Feng L., Qi X.R., Zhou X.J., Maitani Y., Wang S.C., Jiang Y., and Nagai T. Pharmaceutical and immunological evaluation of a single-dose hepatitis B vaccine using PLGA microspheres. J. Control. Release 112 (2006) 35-42
11. Fischer S., Schlosser E., Mueller M., Csaba N., Merkle H.P., Groettrup M., and Gander B. Concomitant delivery of a CTL-restricted peptide antigen and CpG ODN by PLGA microparticles induces cellular immune response. J. Drug Target. 17 8 (2009) 652-661
12. Gomez A.M., Rhodes J.C., and Deepe Jr. G.S. Antigenicity and immunogenicity of an extract from the cell wall and cell membrane of Histoplasma capsulatum yeast cells. Infect. Immun. 59 (1991) 330-336
13. Gomez F.J., Gomez A.M., and Deepe Jr. G.S. An 80-kDa antigen from Histoplasma capsulatum that has homology to heat shock protein 70 induces cell mediated immune responses and protection in mice. Infect. Immun. 60 (1992) 2565-2571
14. Gómez B.L., Figueroa J.I., Hamilton J., Diez S., Rojas M., Tobón A., Restrepo A., and Hay R.J. Detection of the 70-kiloDalton Histoplasma capsulatum antigen in serum of histoplasmosis patients: correlation between antigenemia and therapy during follow-up. J. Clin. Microbiol. 37 (1999) 675-680
15. Green L.C., Ruiz De Luzuriaga K., Wagner D.A., Rand W., Istfand N., Young V.R., and Tannenbaun S.R. Nitrate biosynthesis in man. Proc. Natl. Acad. Sci. U.S.A. 78 (1981) 7764-7768
16. Gupta R.K., Chang A.-C., Griffin P., Rivera R., Guo Y.-Y., and Siber G.R. Determination of protein loading in biodegradable polymer microspheres containing tetanus toxoid. Vaccine 15 6/7 (1997) 672-678
17. Johansen P., Gander B., Merkle H.P., and Sesardic D. Ambiguities in the preclinical quality assessment of microparticulate vaccines. TIBTECH 18 (2000) 203-211
18. Lima K.M., and Rodrigues Jr. J.M. Poly-dl-lactide-co-glycolide microspheres as a controlled release antigen delivery system. Braz. J. Med. Biol. Res. 32 (1999) 171-180
19. Lima K.M., Santos S.A., Lima V.M., Coelho-Castelho A.A., Rodrigues Jr. J.M., and Silva C.L. Single dose of a vaccine based on DNA encoding mycobacterial HSP-65 protein plus TDM-loaded PLGA microspheres protects mice against a virulent strain of Mycobacterium tuberculosis. Gene Ther. 10 (2003) 678-685
20. Malyala P., O'Hagan D.T., and Singh M. Enhancing the therapeutic efficacy of CpG oligonucleotides using biodegradable microparticles. Adv. Drug Deliv. Rev. 61 (2009) 218-225
21. Medeiros A.I., Sá-Nunes A., Soares E.G., Peres C.M., Silva C.L., and Faccioli L.H. Blockade of endogenous leukotrienes exacerbates pulmonary histoplasmosis. Infect. Immun. 72 3 (2004) 1637-1644
22. Medeiros A.I., Sá-Nunes A., Turato W.M., Secatto A., Frantz F.G., Sorgi C.A., Serezani C.H., Deepe Jr. G.S., and Faccioli L.H. Leukotrienes are potent adjuvant during fungal infection: effects on memory T cells. J. Immunol. 181 (2008) 8544-8551
23. Men Y., Thomasin C., Merkle H.P., Gander B., and Corradin G. A single administration of tetanus toxoid in biodegradable microspheres elicits T cell and antibody responses similar or superior to those obtained with aluminum hydroxide. Vaccine 13 7 (1995) 683-689
24. Nicolete R., Lima K.M., Rodrigues Jr. J.M., Baruffi M.D., Medeiros A.I., Bentley M.V.L.B., Silva C.L., and Faccioli L.H. In vitro e in vivo activities of leukotrienes B4-loaded biodegradable microspheres. Prostaglandins Other Lipid Mediat. 83 (2007) 121-129
25. Nicolete R., Rius C., Piqueras L., Jose P.J., Sorgi C.A., Soares E.G., Sanz M.J., and Faccioli L.H. Leukotriene B4-loaded microspheres: a new therapeutic strategy to modulate cell activation. BMC Immunol. 9 (2008) 1-11
26. Sá-Nunes A., Medeiros A.I., Nicolete R., Frantz F.G., Panuntocastelo A., Silva C.L., and Faccioli L.H. Efficacy of cell-free antigens in evaluating cell immunity and inducing protection in a murine model of histoplasmosis. Microbes Infect. 7 (2005) 584-592
27. Schlosser E., Mueller M., Fischer S., Basta S., Busch D.H., Gander B., and Groettrup M. TLR ligands and antigen need to be coencapsulated into the same biodegradable microsphere for the generation of potent cytotoxic T lymphocyte responses. Vaccine 26 (2008) 1626-1637
28. Sinha V.R., and Trehan A. Biodegradable microspheres for protein delivery. J. Control. Release 90 (2003) 261-280
29. Trombone A.P.F., Silva C.L., Almeida L.P., Rosada R.S., Lima K.M., Oliver C., Jamur M.C., and Coelho-Castelo A.A.M. Tissue distribution of DNA-Hsp65/TDM-loaded PLGA microspheres and uptake by phagocytic cells. Genet. Vac. Ther. 5 9 (2007) 1-8
30. Underhill D.M., and Ozinsky A. Phagocytosis of microbes: complexity in action. Annu. Rev. Immunol. 20 (2002) 825-852
31. Wheat L.J. Histoplasmosis: a review for clinicians from non-endemic areas. Mycoses 49 (2006) 274-282
32. Woods J.P. Histoplasma capsulatum molecular genetics, pathogenesis and responsiveness to its environment. Fungal Genet. Biol. 35 (2002) 81-97
33. Wüthrich M., Filutowicz H.I., Warner T., Deepe Jr. G.S., and Klein B.S. Vaccine immunity to pathogenic fungi overcomes the requirement for CD4 help in exogenous antigen presentation to CD8+ T cells: implications for vaccine development in immune-deficient hosts. J. Exp. Med. 197 (2003) 1405-1416